MS-20 on Gut Microbiota and Risk/Severity of Cachexia in Pancreatic Cancer Patients

NCT04600154 · clinicaltrials.gov ↗

NA

Phase

UNKNOWN

Status

40

Enrollment

OTHER

Sponsor class

Conditions

Pancreatic Cancer
Cachexia
Chemotherapy Effect

Interventions

DRUG: MS-20
OTHER: Placebo

Sponsor

National Taiwan University Hospital

Collaborators

[object Object]